Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant

NARecruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

March 19, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

November 30, 2026

Conditions
Transplant;Failure,KidneyTransplant; Failure, LiverAdherence, MedicationAdherence, PatientAdherence, Treatment
Interventions
BEHAVIORAL

mHealth Messaging Intervention Group

Participants will receive an electronic pill box; the research team will instruct participants on how to use this device. Participants will be asked to use the electronic pill box for their prescribed medicines for the duration of the study (up to 16 months). During the 12-week micro-randomized trial, participants will be randomized within person to receive (1) adherence support text messages or (2) no text message after each missed dose, and (1) praise text message or (2) no text message after each on time dose. Dose timing will be determined based on participant report of when they typically take their tacrolimus or sirolimus medicine.

Trial Locations (1)

21287

RECRUITING

Johns Hopkins, Baltimore

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Johns Hopkins University

OTHER